A Long-Term Survivor of Metastatic Pancreatic Adenocarcinoma: Free of Recurrence 12 Years After Treatment of Oligometastatic Disease

Aggressive local therapy for patients with oligometastatic pancreatic ductal adenocarcinoma (PDAC) has traditionally not been pursued due to high rates of distant progression. We describe a 62-year-old male initially presenting with resectable PDAC who underwent the Whipple procedure but developed m...

Descripción completa

Detalles Bibliográficos
Autores principales: Stahl, John M, Walther, Zenta, Chang, Bryan W, Hochster, Howard S, Johung, Kimberly L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333949/
https://www.ncbi.nlm.nih.gov/pubmed/28293485
http://dx.doi.org/10.7759/cureus.1007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333949/
https://www.ncbi.nlm.nih.gov/pubmed/28293485
http://dx.doi.org/10.7759/cureus.1007

Ejemplares similares